Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

DDB, DOST-FNRI to launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, will officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

PRRD reappoints Cuy as Chairperson of DDB

Secretary Catalino S. Cuy was given a fresh mandate as the Chairperson of the Dangerous Drugs Board (DDB).

This was confirmed after President Rodrigo Duterte signed his reappointment papers on 21 January 2020. Secretary Cuy was first appointed at the DDB in January 2018 serving the remainder of the term of his predecessor.

Read more ...

DDB’s response to the recommendations of the Vice President on the campaign against illegal drugs

The Dangerous Drugs Board notes the recommendations of Vice President Leni Robredo on the anti-drug campaign. The agency keeps in mind the ultimate goal of establishing drug-free communities as a serious commitment of the Duterte Administration.

Read more ...

(Facility based)
CY 2007

AGE : Mean age of 28 years
SEX : Ratio of male to female 9:1
CIVIL STATUS : Single 56.94%
OCCUPATION : Unemployed 32.82%
EDUCATIONAL ATTAINMENT : High School level 30.62%
ECONOMIC STATUS:Average monthly family income P14,980.59
PLACE OF RESIDENCE : Urban (specifically NCR)
DURATION OF DRUG TAKING : More than six (6) years
NATURE OF DRUG – TAKING : Poly drug use**
DRUGS OF ABUSE : Methamphetamine Hydrochloride (Shabu)
                                 Cannabis (Marijuana)
                                 Inhalants (Contact Cement Adhesive)

*Residential and Out-Patient Facilities

**Poly drug users -  abuse of more than one (1) drug


For 2007, more males were admitted in most centers nationwide, with male-female ratio 9:1. As to age, the youngest is 9 years old, the oldest 74, the average or mean age, 28 years old. Highest percent distributions of clients fall under the age bracket of 25 to 29 and 15 to 19 years old, with 19.03 percent and 18.02 percent admission, respectively.

More than half, 56.94 percent, of the center clients were married while 24.33 percent were single. It was also noted that there were 10.94 percent who have live-in partners while 6.55 percent were separated prior to their rehabilitation.

As regards to highest educational attainment prior to their confinement to the centers, 32.62 percent (1,310) of the patients have reached high school level and 27.63 percent (1,182), college level.

With regard to their status prior to rehabilitation, of the 4,278 clients 32.82 percent were unemployed, while 24.54 percent were workers, either skilled or unskilled.

The average monthly income is Php 14,980.59


(Facility - Based)
CY 2007

                                                   MALE             FEMALE       GRAND TOTAL
NEW ADMISSIONS 2,555 59.72 284 6.64 2,839 66.36
READMISSIONS 571 13.35 46 1.08 617 14.42
OUT - PATIENT 741 17.32 81 1.89 822 19.21
T O T A L 3,867 90.39 411 9.61 4,278 100.00

* Total Reported Cases from Residential and Out-Patient Facilities



For 2007, a total of 4,278 cases were admitted in 55 residential and 3 out-patient centers nationwide. Of this, 3,456 clients were admitted in the treatment facilities while 822 were from outpatient centers. In a residential treatment facility, patients are required to stay for a minimum of six months to a maximum of one year, either on a voluntary or compulsory confinement basis. In an out-patient facility, dependents are diagnosed for their drug-taking behavior and required to report for treatment on a regular basis for a certain period of time.

As compared to 2006, a 9.04 percent decrease rate was observed in admission of clients. The decrease in admission may be brought about by the closure of some centers due to failure to comply with requirements or to apply for accreditation to the  DOH. Another reason for the decrease may be attributed to the relentless efforts on the demand and supply reduction campaign of the government

Of those (3,456) in the residential facilities, 2,839 or 82.14 percent were new admissions while 617 or 17.85 percent were relapsed or readmitted cases.



(Facility Based)
CY 2007

DRUGS USED / ABUSED NEW ADMISSIONS RE-ADMISSIONS OUT-PATIENT GRAND TOTAL % based on the total number of responses (5,673) % based on the total number of admissions (4,278)
1. Methamphetamine Hydrochloride(Shabu) 2,035 527 451 3,013 53.11 70.43
2. Cannabis (Marijuana) 1,162 259 435 1,856 32.72 43.38
3. Inhalants (Contact Cement Ex.: Rugby) 189 27 141 357 6.29 8.35
4. Benzodiazepines 116 37 1 154 2.71 3.60
5. Cough / Cold Preparations 51 20 1 72 1.27 1.68
6. MDMA (Ecstasy) 47 15 4 66 1.16 1.54
7. Nalbuphine Hydrochloride (Nubain) 27 18   45 0.79 1.05
8. Ketamine 16 10   26 0.46 0.61
9. Solvent 14     14 0.25 0.33
10. Psilocybin (Katsubong, Magic Mushroom) 8 4   12 0.21 0.28

* Total Reported Cases from Residential and Out-Patient Facilities